Biotech Values

[ThomasS]

MNTA: final thought irt: M-118

The "active partnering discussions" would likely achieve apogee at approximately the same date as the expiration of the NVS standstill agreement with MNTA (July 2008; NVS owns 13.5% of MNTA, currently). I find this interesting.


Complete M-118 PIIa trial and make data available in the "second half of the year."
Commence 2 planned PIIb M-118 studies in 2H 2008 (medical management of unstable angina PCI)
Confirmed active partnering discussions for M-118 for partnering after PIIa with "appropriate Pharmaceutical partners." --IMO, this could be big news if/when it occurs, due to the potential market size.